Another mechanism of vandetanib resistance was reported in a patient with NSCLC and CCDC6-RET, in which acquisition of RET S904F resulted in increased basal kinase activity (Nakaoku et al. 2018). The gene discussed is RET; the disease is non-small cell lung carcinoma.